FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q2 2019

SEC EDGAR SourceSEC Filings

Top Holdings104 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
AABAAABADelisted
Fund

ALTABA INC

28.4M$2B12.8%
3 qtrssince 2018-Q4
Increased
64
CELGCELGDelisted

CELGENE CORP

15.4M$1.4B9.3%
2 qtrssince 2019-Q1
Increased
96
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

3.6M$1.1B7.0%
Increased
RHTRHTDelisted

RED HAT INC

5.1M$963.7M6.3%
3 qtrssince 2018-Q4
Increased
87
APCAPCDelisted

ARKO Petroleum Corp.

10.5M$738.4M4.8%
1 qtr
New
88
WCGWCGDelisted

WELLCARE HEALTH PLANS INC

2.2M$634.3M4.1%
2 qtrssince 2019-Q1
Increased
93

WABTEC CORP

6.6M$471.3M3.1%$66.40+3.96%
3 qtrssince 2018-Q4
Increased
61

IQVIA HOLDINGS INC

2.6M$415M2.7%$121.59+32.33%
3 qtrssince 2018-Q4
Increased
63
8.5M$393.8M2.6%
3 qtrssince 2018-Q4
Increased
75

FIDELITY NATIONAL INFO SERV

2.8M$348.7M2.3%$94.21+14.80%
3 qtrssince 2018-Q4
Increased
68

ANTHEM INC

1.1M$296.3M1.9%$240.95+7.34%
3 qtrssince 2018-Q4
Increased
60

CHARTER COMMUNICATIONS INC - CLASS A

700,405$276.8M1.8%$285.08+38.62%
3 qtrssince 2018-Q4
Decreased
0

GENERAL DYNAMICS CORP

1.3M$242.8M1.6%$135.91+14.43%
3 qtrssince 2018-Q4
Increased
59
PLYAPLYADelisted

PLAYA HOTELS & RESORTS NV

30.6M$236M1.5%
3 qtrssince 2018-Q4
Unchanged
0
3.6M$229.7M1.5%
3 qtrssince 2018-Q4
Decreased
0

SHERWIN-WILLIAMS CO/THE

465,699$213.4M1.4%$136.78+5.45%
2 qtrssince 2019-Q1
Increased
58

VISA INC-CLASS A SHARES

1.2M$206.1M1.3%$124.91+31.97%
3 qtrssince 2018-Q4
Decreased
0

EQUIFAX INC

1.5M$198M1.3%$87.63+46.63%
3 qtrssince 2018-Q4
Decreased
0
EQIXEQIX
REIT

EQUINIX INC

383,132$193.2M1.3%$309.48+44.48%
3 qtrssince 2018-Q4
Decreased
0

S&P GLOBAL INC

840,786$191.5M1.2%$198.90+8.48%
2 qtrssince 2019-Q1
Decreased
0
$15.4B
AUM
104
Positions
Q2 2019
Filing
Rating · 1.0
Quarterly Portfolio Change
-3%Q1'19$13.3B+16%Q2'19$15.4B
Activity profile
$ moved · Q2'19
New22%Increased47%Decreased19%Exited12%
Composition
Equity vs derivatives
Equity93%Puts7%Calls0%
Holding period
Avg 1.8 quarters
<1Q18%1-4Q78%1-2Y0%2Y+4%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $15.4B across 104 positions as of Q2 2019. Top holdings: AABA (12.8%), CELG (9.3%), SPY (7.0%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1/5.0.

Q2 2019 Summary

Active quarter - 19 new positions, 9 exits, 34 increased. Top move: CELG (INCREASED, conviction 96). Portfolio: $15.4B across 104 positions.

Top holdings by portfolio weight

Total AUM$14B
AABA12.80%
CELG9.29%
RHT6.27%
APC4.80%
WCG4.13%
WAB3.07%
IQV2.70%
AR22.56%
FIS2.27%
ELV1.93%
Other1.80%

Portfolio allocation by GICS sector

Sectors10
Unknown53.14%
Healthcare16.33%
Industrials6.41%
Energy5.20%
Communication Services5.00%
Technology4.43%
Financial Services3.73%
Consumer Cyclical2.67%
Real Estate1.59%
Basic Materials1.50%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Weak(1.0 / 5.0)
Track RecordNo data
Conviction43
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q3 2024 Q2 2026+8.5M shares+$314.1M
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 Q2 2026+9M shares+$755.7M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used